In line with previous findings in colorectal adenocarcinoma (Aasebo et al. 2019), we found MSI to co-occur with BRAF mutations in colorectal NEC (4/4 MSI harboured BRAF mutation). The gene discussed is BRAF; the disease is colorectal adenocarcinoma.